Ind-Swift Laboratories reported a Rs 58.99 crore shortfall in its preferential issue funds due to a lapsed warrant conversion. While the monitoring agency cited potential impact, the company stated sufficient internal accruals are available for its expansion plans.
Ind-Swift Laboratories Reports Preferential Issue Shortfall, Management Reassures on Expansion
Ind-Swift Laboratories has reported a total of Rs 255.61 crore raised against a planned preferential issue size of Rs 314.60 crore, resulting in a shortfall of Rs 58.99 crore. Reader Takeaway: Company faces fund shortfall but has internal accruals for expansion plans. ## What just happened The Monitoring Agency, CARE Ratings, in its report for the quarter ending June 30, 2026, highlighted a Rs 58.99 crore shortfall in the funds raised via a preferential issue. This occurred because an allottee, Saral Incorporated VCC Sub Fund 1, failed to convert 6,500,000 warrants within the 18-month period. ## Why this matters The Monitoring Agency noted that this shortfall could adversely impact the execution of the company's stated objects. However, the Board of Directors has clarified that Ind-Swift Laboratories possesses adequate internal accruals and cash balances to proceed with its planned projects. ## The backstory Ind-Swift Laboratories had planned to raise Rs 314.60 crore through a preferential issue. The company has been utilizing these funds for various expansion-related activities. The monitoring agency's role is to ensure the proper utilization of these funds. ## What changes now While a portion of the planned funds will not be realized, the company's management is confident in its ability to fund its expansion plans using its own resources. The focus now shifts to the execution of these projects with the available funds. ## Risks to watch The primary risk identified by the monitoring agency is the potential adverse impact on the execution of stated objects due to the fund shortfall. Investors should monitor project progress to ensure no significant delays occur. ## Utilization of Funds During the quarter ended June 30, 2026, Rs 19.82 crore was utilized for registration and stamp duty, land purchase, and advances for machinery procurement. Total utilized funds stand at Rs 251.84 crore, with Rs 3.77 crore remaining unutilized, currently in fixed deposits and a warrant receipt account. ## Operational Control Observation CARE Ratings observed fund commingling where Rs 0.24 crore was transferred from the preferential issue account to a current account for forex transactions. The company explained this was routed via an Authorized Dealer bank and aligned with the offer document's objectives. ## Context metrics (time-bound) * **Issue Size:** Rs 314.60 crore * **Amount Raised:** Rs 255.61 crore * **Funding Shortfall:** Rs 58.99 crore * **Unutilized Proceeds (as of June 30, 2026):** Rs 3.77 crore * **Quarterly Utilization (ended June 30, 2026):** Rs 19.82 crore
